Industry News
Pharmaceutical Industry News
Sanofi ordered by French court to compensate for epilepsy drug side effect: report
Sanofi ordered by French court to compensate for epilepsy drug side effect: report zbecker Mon, 05/16/2022 - 10:12
Bristol Myers’ Opdivo-Yervoy combo misses mark in newly diagnosed bladder cancer
Bristol Myers' Opdivo-Yervoy combo misses mark in newly diagnosed bladder cancer fkansteiner Mon, 05/16/2022 - 09:03
Otsuka drops beleaguered Akebia after FDA snub. Will AstraZeneca follow suit with FibroGen?
Otsuka drops beleaguered Akebia after FDA snub. Will AstraZeneca follow suit with FibroGen? aliu Mon, 05/16/2022 - 08:49
Seagen CEO Siegall resigns after domestic abuse arrest
Seagen CEO Siegall resigns after domestic abuse arrest kdunleavy Mon, 05/16/2022 - 08:39
Biogen’s Aduhelm can’t catch a break even in Alzheimer’s trials as neurologists worry about safety, efficacy
Biogen's Aduhelm can't catch a break even in Alzheimer's trials as neurologists worry about safety, efficacy badams Mon, 05/16/2022 - 07:24
¿Hasta dónde llegarías cuando un ser querido tiene una enfermedad terminal?
Tener acceso a un medicamento experimental suele implicar procesos poco claros y decisiones éticas difíciles.
Lilly’s highly anticipated diabetes drug Mounjaro wins FDA blessing
Lilly's highly anticipated diabetes drug Mounjaro wins FDA blessing kdunleavy Fri, 05/13/2022 - 17:26
Startups Prescribing A.D.H.D Drugs on TikTok Raise Diagnosis Concerns
Buzzy start-ups promising easy access to mental health medication found an eager market on social media. Should anyone be looking for treatment on TikTok, though?
Driving Commercial Success in New Era of Biopharmaceutical Innovation
Driving Commercial Success in New Era of Biopharmaceutical Innovation jfrasor Fri, 05/13/2022 - 16:00
Trial for controversial China-made Alzheimer’s drug aborted as capital raise hits snag, COVID hurts sales
Trial for controversial China-made Alzheimer’s drug aborted as capital raise hits snag, COVID hurts sales aliu Fri, 05/13/2022 - 15:58
3 UK pharma companies go broke, costing 1,000 employees their jobs: reports
3 UK pharma companies go broke, costing 1,000 employees their jobs: reports zbecker Fri, 05/13/2022 - 10:20
Bora scoops up plant from Eden, the company at the center of the Genentech theft saga
Bora scoops up plant from Eden, the company at the center of the Genentech theft saga fkansteiner Fri, 05/13/2022 - 09:59
Novartis’ Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet aliu Fri, 05/13/2022 - 09:34
Mitsubishi Tanabe scores FDA nod for oral version of its ALS drug Radicava
Mitsubishi Tanabe scores FDA nod for oral version of its ALS drug Radicava kdunleavy Fri, 05/13/2022 - 09:33
Bristol Myers sells NY biologics plant for $160M to fuel Lotte’s drugmaking ambitions
Bristol Myers sells NY biologics plant for $160M to fuel Lotte's drugmaking ambitions fkansteiner Fri, 05/13/2022 - 08:41
FDA halts UCB’s psoriasis drug application over facility inspection issues
FDA halts UCB's psoriasis drug application over facility inspection issues aarmstrong Fri, 05/13/2022 - 08:21
Fierce Pharma Asia—Takeda’s patent cliff and rare disease setback; FDA’s censure of Sun, Aurobindo
Fierce Pharma Asia—Takeda's patent cliff and rare disease setback; FDA's censure of Sun, Aurobindo aliu Fri, 05/13/2022 - 07:41
Amgen finds a dance partner in Lance Bass, urging psoriatic arthritis patients to do a ‘Double Take’ on the disease
Amgen finds a dance partner in Lance Bass, urging psoriatic arthritis patients to do a ‘Double Take’ on the disease badams Fri, 05/13/2022 - 04:19
GSK’s ViiV, Horizon and Pfizer earn top scores from U.S. patient groups: survey
GSK's ViiV, Horizon and Pfizer earn top scores from U.S. patient groups: survey nmissakian Thu, 05/12/2022 - 18:03
When Hope Hinges on an Unapproved Drug
The limits of expanded access to experimental drugs.